Reckitt Benckiser Group (LON:RB) had its price target cut by Kepler Capital Markets from GBX 7,300 ($99.00) to GBX 7,000 ($94.93) in a report released on Monday. They currently have a hold rating on the stock.

Several other research analysts have also recently commented on RB. JPMorgan Chase & Co. cut their price target on Reckitt Benckiser Group from GBX 7,200 ($97.64) to GBX 6,900 ($93.57) and set a neutral rating on the stock in a research note on Friday, September 15th. Jefferies Group cut their price target on Reckitt Benckiser Group from GBX 8,150 ($110.52) to GBX 7,500 ($101.71) and set a hold rating on the stock in a research note on Friday, September 15th. Goldman Sachs Group cut their price target on Reckitt Benckiser Group from GBX 8,130 ($110.25) to GBX 7,920 ($107.40) and set a neutral rating on the stock in a research note on Thursday, September 21st. Morgan Stanley reiterated an overweight rating and issued a £100 ($135.61) price target on shares of Reckitt Benckiser Group in a research note on Thursday, September 21st. Finally, Berenberg Bank reiterated a buy rating and issued a GBX 8,500 ($115.27) price target on shares of Reckitt Benckiser Group in a research note on Thursday, September 28th. Two analysts have rated the stock with a sell rating, twelve have issued a hold rating and nine have given a buy rating to the stock. Reckitt Benckiser Group presently has a consensus rating of Hold and an average price target of GBX 7,664.55 ($103.94).

Reckitt Benckiser Group (LON:RB) opened at GBX 6,767 ($91.77) on Monday. Reckitt Benckiser Group has a one year low of GBX 6,299 ($85.42) and a one year high of GBX 8,110.43 ($109.99). The company has a market capitalization of $47,710.00 and a PE ratio of 2,263.21.

In other news, insider Christopher Sinclair bought 2,800 shares of the business’s stock in a transaction on Wednesday, November 1st. The stock was purchased at an average cost of GBX 6,597 ($89.46) per share, for a total transaction of £184,716 ($250,496.34). Also, insider Adrian Nevil Hennah bought 2,285 shares of the business’s stock in a transaction on Wednesday, November 8th. The stock was purchased at an average price of GBX 6,567 ($89.06) per share, with a total value of £150,055.95 ($203,493.29).

TRADEMARK VIOLATION WARNING: “Reckitt Benckiser Group (RB) Price Target Lowered to GBX 7,000 at Kepler Capital Markets” was posted by Watch List News and is the property of of Watch List News. If you are accessing this piece of content on another domain, it was illegally stolen and reposted in violation of international copyright legislation. The correct version of this piece of content can be viewed at https://www.watchlistnews.com/reckitt-benckiser-group-rb-price-target-lowered-to-gbx-7000-at-kepler-capital-markets/1803831.html.

Reckitt Benckiser Group Company Profile

Reckitt Benckiser Group plc is a manufacturer and marketer of health, hygiene and home products. The Company’s segments include ENA and DvM. The ENA segment consists of Europe, Russia/Commonwealth of Independent States (CIS), Israel, North America, Australia and New Zealand. The DvM segment consists of North Africa, Middle East (excluding Israel) and Turkey, Africa, South Asia, North Asia, Latin America, Japan, Korea and the Association of Southeast Asian Nations (ASEAN).

Analyst Recommendations for Reckitt Benckiser Group (LON:RB)

Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.